It is known that PALB2 cancer-related missense variants L393W, T1030I and L1143P in the WD40 domain could interfere with PALB2 association with RAD51 and BRCA2, prompting carriers to be defective in DNA damage repair by HR, leading to an increased sensitivity to IR-treatment [144]. Here, RAD51 is linked to cancer.